OBJECTIVE: Pleural effusions in patients with lymphoma that are assumed to
be related to malignancy are attributed to either lymphatic obstruction by
tumour with resultant decreased clearance of pleural fluid, or direct tumou
r involvement of the pleura, The purpose of our study was to determine how
often pleural or extrapleural disease was detected by computed tomography (
CT) of patients with pleural effusions and primary or recurrent lymphoma.
METHODS AND MATERIALS: We reviewed CT examinations showing evidence of pleu
ral effusion in 61 patients with a diagnosis of primary or recurrent lympho
ma and no history of other systemic disorders, including infection. The stu
dy population consisted of patients with non-Hodgkin's lymphoma (n = 44) or
Hodgkin's disease (n = 17); both primary disease (n = 11) and recurrent di
sease (IL = 50) were represented. Each CT examination was evaluated for the
presence of disease involving the visceral and parietal pleura and extrapl
eural space, mediastinal adenopathy, and pulmonary parenchymal disease.
RESULTS: Fourteen patients (23%) (nine with non-Hodgkin's lymphoma and five
with Hodgkin's disease) had parietal pleural disease (thickening or nodule
s), Eighteen patients (30%) (14 with non-Hodgkin's lymphoma, four with Hodg
kin's disease) had tumour or enlarged lymph nodes in the extrapleural space
, Forty-three patients (70%) had mediastinal lymphadenopathy, Patients who
received intravenous contrast did not have evidence of visceral pleural abn
ormalities or underlying pulmonary parenchymal disease,
CONCLUSION: Forty-one percent of the patients with lymphoma and pleural eff
usions had CT evidence of pleural and/or extrapleural disease. The majority
of the patients with extrapleural disease had adjacent posterior mediastin
al disease. (C) 1999 The Royal College of Radiologists.